Search research articles
Contact Us
Filters
Showing results (11-20 of 188) with videos related to
Page
of 19
Sort By:
Biometrics
|
August 21, 2013
Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimes
Peter F Thall, Hoang Q Nguyen, Thomas M Braun, et al.
Cureus
|
December 16, 2024
The Synchronous Diagnosis of Multiple Myeloma (MM) and Chronic Myeloid Leukemia (CML)
Shinoj Pattali, Shimin Hu, Qaiser Bashir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection
Qaiser Bashir, Lauren A Langford, Simrit Parmar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 10, 2015
Clinical significance of acquired cytogenetic clones in patients with treated follicular lymphoma
Xiaohong I Wang, C Cameron Yin, Muzaffar H Qazilbash, et al.
Acta Haematologica
|
January 17, 2017
Immune-Mediated Neuropathies following Autologous Stem Cell Transplantation for Multiple Myeloma: Case Series and Review of the Literature
Ghulam Rehman Mohyuddin, Jacqueline Uy, Honhar Medhavi, et al.
American Journal of Hematology
|
June 25, 2010
The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes
Manish Sharma, Sofia R Qureshi, Richard E Champlin, et al.
American Journal of Hematology
|
September 3, 2005
Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia
Muzaffar H Qazilbash, Zhenhong Qu, Chitra Hosing, et al.
Blood Cancer Journal
|
November 15, 2023
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies
Susan Bal, Noel Estrada-Merly, Luciano J Costa, et al.
European Journal of Haematology
|
December 24, 2016
Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma
Suzanne C Gettys, Alison Gulbis, Kaci Wilhelm, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 16, 2014
Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease
Amir Hamdi, Aimaz Afrough, Tariq Muzzafar, et al.
Page
of 19
Search research articles
Search
Showing results (11-20 of 188) with videos related to
Sort By:
Page
of 19
Biometrics
|
August 21, 2013
Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimes
Peter F Thall, Hoang Q Nguyen, Thomas M Braun, et al.
Cureus
|
December 16, 2024
The Synchronous Diagnosis of Multiple Myeloma (MM) and Chronic Myeloid Leukemia (CML)
Shinoj Pattali, Shimin Hu, Qaiser Bashir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection
Qaiser Bashir, Lauren A Langford, Simrit Parmar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 10, 2015
Clinical significance of acquired cytogenetic clones in patients with treated follicular lymphoma
Xiaohong I Wang, C Cameron Yin, Muzaffar H Qazilbash, et al.
Acta Haematologica
|
January 17, 2017
Immune-Mediated Neuropathies following Autologous Stem Cell Transplantation for Multiple Myeloma: Case Series and Review of the Literature
Ghulam Rehman Mohyuddin, Jacqueline Uy, Honhar Medhavi, et al.
American Journal of Hematology
|
June 25, 2010
The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes
Manish Sharma, Sofia R Qureshi, Richard E Champlin, et al.
American Journal of Hematology
|
September 3, 2005
Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia
Muzaffar H Qazilbash, Zhenhong Qu, Chitra Hosing, et al.
Blood Cancer Journal
|
November 15, 2023
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies
Susan Bal, Noel Estrada-Merly, Luciano J Costa, et al.
European Journal of Haematology
|
December 24, 2016
Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma
Suzanne C Gettys, Alison Gulbis, Kaci Wilhelm, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 16, 2014
Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease
Amir Hamdi, Aimaz Afrough, Tariq Muzzafar, et al.
Page
of 19